XML 109 R67.htm IDEA: XBRL DOCUMENT v3.25.1
Segment information (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2024
USD ($)
segment
Dec. 31, 2023
USD ($)
Segment Reporting Information [Line Items]    
Number of Operating Segments | segment 1  
Number of reportable segments | segment 1  
Collaboration revenue $ 9,041 $ 14,018
Less:    
In-process research and development (152,344) (80,802)
General and administrative (32,955) (19,657)
Total operating expenses (314,841) (123,548)
Loss from operations (305,800) (109,530)
Interest income 12,837 2,724
Net loss (292,963) (106,806)
Single reportable segment    
Segment Reporting Information [Line Items]    
Collaboration revenue 9,041 14,018
Less:    
In-process research and development (152,344) (80,802)
Other (35,335) (11,278)
Indirect research and development (28,764) (11,811)
General and administrative (32,955) (19,657)
Total operating expenses (314,841) (123,548)
Loss from operations (305,800) (109,530)
Interest income 12,837 2,724
Net loss (292,963) $ (106,806)
Single reportable segment | Varegacestat    
Less:    
Direct research and development expenses (27,954)  
Single reportable segment | IM-3050    
Less:    
In house research and development expenses (24,130)  
Single reportable segment | IM-3050    
Less:    
In house research and development expenses $ (13,359)